M-tron Industries, Inc. (MPTI)
NYSEAMERICAN: MPTI · Real-Time Price · USD
52.20
+0.13 (0.25%)
Nov 4, 2024, 4:00 PM EST - Market closed

Company Description

M-tron Industries, Inc. engages in the design, manufacture, and marketing of frequency and spectrum control products in the United States and internationally.

The company’s products include radio frequency, microwave, and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; high frequency and performance OCXOs, integrated PLL OCXOs, TCXOs, VCXOs, and low jitter and harsh environment oscillators; crystal resonators, integrated microwave assemblies; and solid-state power amplifier products.

Its products are used in applications in the commercial and military aerospace, defense, space, avionics, and other markets.

The company was founded in 1965 and is headquartered in Orlando, Florida.

M-tron Industries, Inc.
M-tron Industries logo
Country United States
Founded 1965
Industry Electronic Components
Sector Technology
Employees 208
CEO Michael Ferrantino

Contact Details

Address:
2525 Shader Road
Orlando, Florida 32804
United States
Phone 407 298 2000
Website mtronpti.com

Stock Details

Ticker Symbol MPTI
Exchange NYSEAMERICAN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001902314
CUSIP Number 55380K109
ISIN Number US55380K1097
Employer ID 46-0457994
SIC Code 3679

Key Executives

Name Position
Michael J. Ferrantino Jr. Chief Executive Officer and Director
William A. Drafts President
Marc Joseph Gabelli Special Advisor to Chairman and Director
Linda M. Biles Executive Vice President of Finance and Secretary
Cameron Pforr Chief Financial Officer

Latest SEC Filings

Date Type Title
Oct 9, 2024 8-K Current Report
Sep 18, 2024 8-K Current Report
Aug 21, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Aug 14, 2024 8-K Current Report
Aug 14, 2024 10-Q Quarterly Report
Jun 18, 2024 8-K Current Report
May 30, 2024 SD Form - SD
May 14, 2024 10-Q Quarterly Report
May 7, 2024 8-K Current Report
Apr 29, 2024 DEF 14A Other definitive proxy statements